G. L. Francis

A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.

P. McNamara, J. Wallace, C. Bagley, 1989, The Biochemical journal.

Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

J. Wallace, F. Ballard, G. Francis, 1989, The Biochemical journal.

Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form.

J. Wallace, F. Ballard, G. Francis, 1988, The Biochemical journal.

Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding.

J. Wallace, C. Bagley, F. Ballard, 1987, Biochemical and biophysical research communications.

Identification of vitronectin as a novel insulin-like growth factor-II binding protein.

J. Mcmurtry, Z. Upton, F. Ballard, 1999, Endocrinology.

Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells

M. Rogers, F. Ballard, I. Priebe, 1995, In Vitro Cellular & Developmental Biology - Animal.

Chicken insulin-like growth factor-I: amino acid sequence, radioimmunoassay, and plasma levels between strains and during growth.

J. Wallace, J. Mcmurtry, R. J. Johnson, 1990, General and comparative endocrinology.

Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.

F. Ballard, G. Francis, M. Ross, 1988, The Biochemical journal.